Questions over the efficacy and safety of hydroxychloroquine continue to be raised following the World Health Organization’s decision to temporarily halt a study of the malaria drug as a potential treatment for COVID-19.
https://www.pharmalive.com/wp-content/uploads/2020/05/WHO-Pauses-Hydroxychloroquine-Arm-of-COVID-19-Study-Following-Safety-Concerns-BioSpace-5-26-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-05-26 10:38:072020-05-28 23:44:46WHO Pauses Hydroxychloroquine Arm of COVID-19 Study